BACKGROUND AND OBJECTIVES: Cervical ectopy has been proposed as a risk factor for chlamydial infection, HIV, and other sexually transmitted diseases (STDs). Ectopy is a histologic phenomenon resulting from a complex interplay of morphologic and hormonal processes. Reproductive hormones influence the production of ectopy during late fetal life, puberty, pregnancy, and with use of oral contraceptives. Ectopy is modified over time by squamous metaplasia and epitheliazation, low pH, trauma, and possibly by cervical infection. STUDY DESIGN: The authors review the histologic development of ectopy from late fetal life to menopause to understand STD risk. RESULTS: Ectopy is often assessed and quantified by direct, unaided observation during speculum examinations. This method may result in inaccurate estimates and misclassification with the transformation zone. CONCLUSION: Valid, reproducible measures of ectopy are necessary for epidemiologic studies to examine the impact of exogenous hormonal contraceptives on the development of ectopy and on potential infection risk.
BACKGROUND AND OBJECTIVES: Cervical ectopy has been proposed as a risk factor for chlamydial infection, HIV, and other sexually transmitted diseases (STDs). Ectopy is a histologic phenomenon resulting from a complex interplay of morphologic and hormonal processes. Reproductive hormones influence the production of ectopy during late fetal life, puberty, pregnancy, and with use of oral contraceptives. Ectopy is modified over time by squamous metaplasia and epitheliazation, low pH, trauma, and possibly by cervical infection. STUDY DESIGN: The authors review the histologic development of ectopy from late fetal life to menopause to understand STD risk. RESULTS: Ectopy is often assessed and quantified by direct, unaided observation during speculum examinations. This method may result in inaccurate estimates and misclassification with the transformation zone. CONCLUSION: Valid, reproducible measures of ectopy are necessary for epidemiologic studies to examine the impact of exogenous hormonal contraceptives on the development of ectopy and on potential infection risk.
Authors: Patricia L Bright; Abigail Norris Turner; Charles S Morrison; Emelita L Wong; Cynthia Kwok; Irina Yacobson; Rachel A Royce; Heidi O Tucker; Paul D Blumenthal Journal: Contraception Date: 2011-03-23 Impact factor: 3.375
Authors: Jeffrey N Roberts; Rhonda C Kines; Hormuzd A Katki; Douglas R Lowy; John T Schiller Journal: J Natl Cancer Inst Date: 2011-04-11 Impact factor: 13.506
Authors: L Brabin; E Fairbrother; D Mandal; S A Roberts; S P Higgins; S Chandiok; P Wood; G Barnard; H C Kitchener Journal: Sex Transm Infect Date: 2005-04 Impact factor: 3.519
Authors: Jordan K Kyongo; Tania Crucitti; Joris Menten; Liselotte Hardy; Piet Cools; Johan Michiels; Sinead Delany-Moretlwe; Mary Mwaura; Gilles Ndayisaba; Sarah Joseph; Raina Fichorova; Janneke van de Wijgert; Guido Vanham; Kevin K Ariën; Vicky Jespers Journal: Clin Vaccine Immunol Date: 2015-03-11
Authors: Audrey E Pettifor; Brooke A Levandowski; Catherine MacPhail; Nancy S Padian; Myron S Cohen; Helen V Rees Journal: Int J Epidemiol Date: 2008-07-09 Impact factor: 7.196
Authors: Julie E Horbul; Stephen C Schmechel; Barrie R L Miller; Stephen A Rice; Peter J Southern Journal: PLoS One Date: 2011-07-27 Impact factor: 3.240